跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 37,006 条关于
“Eque-cel”
全部
37,006
临床试验
30,845
药物
3,004
机构
140
资讯
3,017
去年
Eque-Cel CAR-T Therapy Demonstrates High Response Rates in Multiple Myeloma Trial
去年
IASO Bio's CAR-T Therapy Shows Sustained Efficacy in Multiple Myeloma Patients with Renal Impairment
2年前
IASO Bio Secures FDA Approval for BCMA CAR-T Therapy in Multiple Autoimmune Diseases
9个月前
IASO Bio's CAR-T Therapy Shows 93.8% Complete Response Rate in High-Risk Multiple Myeloma Patients
2年前
IASO Bio's CAR-T Therapy Shows 100% Response Rate in High-Risk Newly Diagnosed Multiple Myeloma Patients
5个月前
IASO Bio Receives Japan PMDA Approval for Phase III CAR-T Trial in Earlier-Line Multiple Myeloma
12个月前
IASO Biotherapeutics Reports Sustained 36-Month Efficacy Data for Fucaso CAR-T Therapy in Multiple Myeloma
去年
Optimal Lymphodepletion Improves Outcomes with Equecabtagene Autoleucel in Multiple Myeloma
前天
FDA Clears IND for IASO208, First China-Originated In Vivo CAR-T to Enter US Clinic
2年前
CARVYKTI® Demonstrates Significant Benefit in High-Risk Multiple Myeloma After One Line of Therapy
第 1 页,共 302 页
上一页
下一页